Investment Professionals with an Edge
Our exclusive focus on healthcare, combined with the proprietary insights of MEDACorp, enables Leerink Swann's analysts to identify key investment controversies and opportunities throughout the industry. With one of the largest healthcare research teams on Wall Street, our analysts are constantly working to deliver leading-edge research for clients seeking success in healthcare investing.
The industry expertise of our analysts is enhanced by the healthcare knowledge of our MEDACorp network . The experienced, practical insights of MEDACorp's over 30,000 members provide support for much of our proprietary and potentially agenda-setting equity research.
Leerink Swann analysts cover:
- Healthcare Strategy
- Pharmaceuticals, Major
- Pharmaceuticals, Specialty
- Medical Supplies and Devices
- Healthcare Services
- Healthcare Technology and Distribution
- Life Science Tools and Diagnostics